Variation in antibiotic prophylaxis selection for coronary artery bypass graft procedures in an era of increasing methicillin-resistant Staphylococcus aureus prevalence

Infect Control Hosp Epidemiol. 2014 Jun;35(6):737-40. doi: 10.1086/676436. Epub 2014 Apr 23.

Authors

Peter P Hsiue¹, Aric L Gregson, Patil Injean, Sitaram Vangala, Ralph G Brindis, Richard J Shemin, David M Shahian, Loren G Miller, Martin F Shapiro, Peyman Benharash, James A McKinnell

Affiliation

¹ Division of Infectious Disease, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California.

PMID: 24799655
PMCID: PMC4169278
DOI: 10.1086/676436

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Antibiotic Prophylaxis / statistics & numerical data*
California
Cephalosporins / therapeutic use*
Coronary Artery Bypass*
Databases, Factual
Drug Therapy, Combination
Drug Utilization
Health Care Surveys
Humans
Methicillin-Resistant Staphylococcus aureus / drug effects*
Practice Patterns, Physicians'*
Staphylococcal Infections / prevention & control*
Vancomycin / therapeutic use*

Substances

Cephalosporins
Vancomycin

Grants and funding